MENU
donate

Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Ghada Sharif, PhD

Lombardi Comprehensive Cancer Center
Presented by Color Street Foundation
Targeting Occult Cancer Cell Subpopulations Driving Metastases Growth
Abstract Report
Summary Report

Dipali Sharma, MS, PhD

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkin
Presented by Color Street Foundation
Racial Disparity in metastatic triple-negative breast cancer in African American women: Unraveling actionable molecular determinants
Abstract Report
Summary Report

PATRICIA SHEEAN, PhD, RDN

Loyola University Chicago
Is lean soft tissue (i.e., skeletal muscle) a potentially modifiable biomarker predictive of prognosis, treatment tolerance and
Abstract Report

HAIFA SHEN, PhD, MD

Houston Methodist Research Institute
Harnessing Vascular and Cellular Depots of Nanotherapeutics for the Treatment of Metastatic Breast Cancer
Abstract Report
Summary Report

Lalita Shevde-Samant, PhD

The University of Alabama at Birmingham
Presented in memory of Heather Holmes
Altering the metastatic immune niche to eradicate established breast cancer metastases
Abstract Report
Summary Report

Yusuke Shiozawa, MD, PhD

Wake Forest University
An osteolytic bone lesion-targeted radiopharmaceutical for bone metastatic breast cancer
Abstract Report
Summary Report

Jawed Siddiqui, PhD

University of Nebraska Medical Center
Presented in memory of Heather Holmes
Therapeutic tareting of GFRAL/RET axis to overcome bone metastasis of breast cancer
Abstract Report
Summary Report

GINA SIZEMORE, PhD

Ohio State University
Targeting Novel Tumor-Stroma Interactions in Breast Cancer Brain Metastases
Abstract Report
Summary Report

Luis Solorio, PhD

Purdue University
Presented in honor of Susan Marr Williamson
Effect of Motion in the Metastatic Microenvironment
Abstract Report
Summary Report

Lou Song, PhD

University of Virginia
Oncogenic TRIM37 is a new driver of metastasis in triple negative breast cancer patients
Abstract Report
Summary Report

Khalid Sossey-Alaoui, PhD

Case Western Reserve University and MetroHealth Medical Center
Role of YB1 in Triple Negative Breast Cancer Metastasis
Abstract Report
Summary Report

DAVID SOTO-PANTOJA, PhD

Wake Forest School of Medicine Comprehensive Cancer Center
Anti-CD47 Immunotherapy as a Treatment for Metastatic Breast Cancer
Abstract Report
Summary Report
donate

SHOP  |  BLOG  |  CALENDAR

Facebook-f Instagram X-twitter Youtube Linkedin-in